Francesco Gentile
Francesco Gentile
Vancouver Prostate Centre
Verified email at prostatecentre.com - Homepage
Title
Cited by
Cited by
Year
Rapid identification of potential inhibitors of SARS‐CoV‐2 main protease by deep docking of 1.3 billion compounds
AT Ton, F Gentile, M Hsing, F Ban, A Cherkasov
Molecular informatics 39 (8), 2000028, 2020
2952020
Deep docking: a deep learning platform for augmentation of structure based drug discovery
F Gentile, V Agrawal, M Hsing, AT Ton, F Ban, U Norinder, ME Gleave, ...
ACS central science 6 (6), 939-949, 2020
45*2020
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
J Lee, LJ Worrall, M Vuckovic, FI Rosell, F Gentile, AT Ton, NA Caveney, ...
Nature communications 11 (1), 1-9, 2020
332020
New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy
F Gentile, JA Tuszynski, KH Barakat
Journal of Molecular Graphics and Modelling 65, 71-82, 2016
282016
Structure based modeling of small molecules binding to the TLR7 by atomistic level simulations
F Gentile, MA Deriu, G Licandro, A Prunotto, A Danani, JA Tuszynski
Molecules 20 (5), 8316-8340, 2015
252015
Novel Allosteric Pathway of Eg5 Regulation Identified through Multivariate Statistical Analysis of Hydrogen-Exchange Mass Spectrometry (HX-MS) Ligand Screening Data
JG Sheff, F Farshidfar, OF Bathe, K Kopciuk, F Gentile, JA Tuszynski, ...
Molecular & Cellular Proteomics 16 (3), 428-437, 2017
152017
Computational characterization of small molecules binding to the human XPF active site and virtual screening to identify potential new DNA repair inhibitors targeting the ERCC1 …
F Gentile, KH Barakat, JA Tuszynski
International journal of molecular sciences 19 (5), 1328, 2018
112018
Assessing and improving the performance of consensus docking strategies using the DockBox package
J Preto, F Gentile
Journal of computer-aided molecular design 33 (9), 817-829, 2019
102019
Modelling DNA repair pathways: recent advances and future directions
F Gentile, JA Tuszynski, KH Barakat
Current pharmaceutical design 22 (23), 3527-3546, 2016
92016
Mathematical and computational modeling in biology at multiple scales
JA Tuszynski, P Winter, D White, CY Tseng, KK Sahu, F Gentile, ...
Theoretical Biology and Medical Modelling 11 (1), 1-42, 2014
92014
Computer‐aided drug design of small molecule inhibitors of the ERCC1‐XPF protein–protein interaction
F Gentile, AH Elmenoufy, G Ciniero, D Jay, F Karimi‐Busheri, KH Barakat, ...
Chemical Biology & Drug Design 95 (4), i-i, 2020
82020
Targeting DNA repair in tumor cells via inhibition of ERCC1–XPF
AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ...
Journal of medicinal chemistry 62 (17), 7684-7696, 2019
82019
Molecular Dynamics and Related Computational Methods with Applications to Drug Discovery
J Preto, F Gentile, P Winter, C Churchill, SI Omar, JA Tuszynski
Workshop on Coupled Mathematical Models for Physical and Nanoscale Systems …, 2018
32018
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair
G Ciniero, AH Elmenoufy, F Gentile, M Weinfeld, MA Deriu, FG West, ...
Cancer Chemotherapy and Pharmacology, 1-9, 2021
22021
Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathway
AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ...
European Journal of Medicinal Chemistry 204, 112658, 2020
22020
A Novel Interaction Between the TLR7 and a Colchicine Derivative Revealed Through a Computational and Experimental Study
F Gentile, MA Deriu, KH Barakat, A Danani, JA Tuszynski
Pharmaceuticals 11 (1), 22, 2018
22018
Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
H Mslati, F Gentile, C Perez, A Cherkasov
Journal of Chemical Information and Modeling 61 (8), 3771-3788, 2021
12021
Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity
G Ciniero, F Gentile, AH Elmenoufy, E Cros-Perrial, FG West, M Weinfeld, ...
Biomedical Science and Engineering 4 (s1), 2021
2021
Bypassing cancer drug resistance mechanisms by tuning ERCC1-XPF and p53 activity
G Ciniero, F Gentile, AH Elmenoufy, E Cros-Perrial, FG West, M Weinfeld, ...
CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY, 63, 2021
2021
Assessing and improving the performance of consensus docking strategies using the DockBox package
J Preto, F Gentile
The FASEB Journal 34 (S1), 1-1, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20